News

Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule

SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing…

1 year ago

Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation

MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on…

1 year ago

Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy

MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on…

1 year ago

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus PreparednessNEW YORK, July 19, 2024 (GLOBE NEWSWIRE)…

1 year ago

Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product

Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 year ago

SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC

As Atlanta United’s Official Craft Beer Partner, SweetWater’s New Brew Celebrates the Rowdiest Fans in MLSATLANTA, July 19, 2024 (GLOBE…

1 year ago

Augmedix to Join Forces with Commure

Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by…

1 year ago

Nicox announces attendance at upcoming conferences

Press Release Nicox announces attendance at upcoming conferencesJuly 19th, 2024 – release at 7:30 am CETSophia Antipolis, FranceNicox SA (Euronext…

1 year ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is…

1 year ago

Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease

- Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong…

1 year ago